An Observational Study of Mechanism of Resistance (MoRe) to Novel Small Molecule Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer

Complete Title: An Observational Study of Mechanism of Resistance (MoRe) to Novel Small Molecule Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer
Trial Phase: N/A
Investigator: Christina Baik

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

N/A
Christina Baik
RG1005609
An Observational Study of Mechanism of Resistance (MoRe) to Novel Small Molecule Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer